Chronic wounds (such as diabetic foot ulcers and pressure ulcers) affect millions of patients worldwide. These non-healing wounds pose major clinical challenges due to persistent inflammation, high infection risk, and impaired tissue regeneration, and incur a substantial healthcare burden, with global wound care costs reaching tens of billions of dollars annually. This unmet need has spurred the development of intelligent wound dressings-advanced bioengineered systems that go beyond conventional passive wound coverings by actively monitoring the wound microenvironment and responding dynamically to promote tissue repair. This review comprehensively examines a broad range of smart wound dressing technologies, including pH-sensitive, temperature-responsive, moisture-responsive, pressure-sensing, electroactive, biosensor-integrated, shape-memory, and controlled drug-releasing systems. We also discuss critical challenges in translating these innovations to clinical practice, such as ensuring biocompatibility and long-term stability in the harsh wound environment, manufacturing scalability and cost-effectiveness, patient comfort and adherence, and navigating regulatory hurdles. By emphasizing recent bioengineering advances and clinical potential, we underscore that intelligent wound dressings represent a paradigm shift in chronic wound management-enabling continuous, personalized therapy with the potential to significantly improve healing outcomes, reduce complications, and improve patient quality of life.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Bioengineering